Currently there is no description available for Patrizia Cavazzoni.
“This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19.”
22 Dec 2021
3
2
Read More
